Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:4058304rdf:typepubmed:Citationlld:pubmed
pubmed-article:4058304lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:4058304lifeskim:mentionsumls-concept:C0024445lld:lifeskim
pubmed-article:4058304lifeskim:mentionsumls-concept:C0259749lld:lifeskim
pubmed-article:4058304lifeskim:mentionsumls-concept:C0023804lld:lifeskim
pubmed-article:4058304lifeskim:mentionsumls-concept:C1705994lld:lifeskim
pubmed-article:4058304lifeskim:mentionsumls-concept:C0445254lld:lifeskim
pubmed-article:4058304lifeskim:mentionsumls-concept:C1513492lld:lifeskim
pubmed-article:4058304pubmed:issue6lld:pubmed
pubmed-article:4058304pubmed:dateCreated1985-11-22lld:pubmed
pubmed-article:4058304pubmed:abstractTextClinical evaluation of 33 male patients affected by multiple symmetric lipomatosis has revealed a previously unreported high prevalence of somatic and autonomic neuropathies. In 84% of the patients, clinical examination revealed signs or symptoms of neural disturbances, ranging from a vibratory sensory loss to severely incapacitating trophic ulcers or Charcot's arthropathy. Electrodiagnostic investigations demonstrated a significant reduction of motor and sensory conduction velocity in the peroneal and sural nerves. Morphometric studies of nerve and muscle biopsies from five patients with multiple symmetric lipomatosis revealed a significant reduction in myelinated fiber density (4435 +/- 593 fibers/mm2 in MSL vs 7660 +/- 800 in controls; p less than 0.05), a selective reduction in the large fibers of 7 to 10 micron in diameter, and signs of chronic denervation-reinnervation processes. Bedside tests for autonomic neuropathy were abnormal in 15 of 20 patients studied. Metabolic studies in these patients confirmed a significant increase in plasma high-density lipoprotein fractions consistent with the diagnosis of hyperalphalipoproteinemia, and a significant reduction in plasma low-density lipoprotein fractions (hypobetalipoproteinemia) associated with a marked enhancement of lipoprotein lipase activity in adipose tissue. Thus, a metabolic factor has to be considered in the pathogenesis of MSL neuropathy.lld:pubmed
pubmed-article:4058304pubmed:languageenglld:pubmed
pubmed-article:4058304pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4058304pubmed:citationSubsetAIMlld:pubmed
pubmed-article:4058304pubmed:statusMEDLINElld:pubmed
pubmed-article:4058304pubmed:monthNovlld:pubmed
pubmed-article:4058304pubmed:issn0025-7974lld:pubmed
pubmed-article:4058304pubmed:authorpubmed-author:FedeleDDlld:pubmed
pubmed-article:4058304pubmed:authorpubmed-author:AngeliniCClld:pubmed
pubmed-article:4058304pubmed:authorpubmed-author:NegrinPPlld:pubmed
pubmed-article:4058304pubmed:authorpubmed-author:EnziGGlld:pubmed
pubmed-article:4058304pubmed:authorpubmed-author:ArmaniMMlld:pubmed
pubmed-article:4058304pubmed:authorpubmed-author:PierobonSSlld:pubmed
pubmed-article:4058304pubmed:issnTypePrintlld:pubmed
pubmed-article:4058304pubmed:volume64lld:pubmed
pubmed-article:4058304pubmed:ownerNLMlld:pubmed
pubmed-article:4058304pubmed:authorsCompleteYlld:pubmed
pubmed-article:4058304pubmed:pagination388-93lld:pubmed
pubmed-article:4058304pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:4058304pubmed:meshHeadingpubmed-meshheading:4058304-...lld:pubmed
pubmed-article:4058304pubmed:meshHeadingpubmed-meshheading:4058304-...lld:pubmed
pubmed-article:4058304pubmed:meshHeadingpubmed-meshheading:4058304-...lld:pubmed
pubmed-article:4058304pubmed:meshHeadingpubmed-meshheading:4058304-...lld:pubmed
pubmed-article:4058304pubmed:meshHeadingpubmed-meshheading:4058304-...lld:pubmed
pubmed-article:4058304pubmed:meshHeadingpubmed-meshheading:4058304-...lld:pubmed
pubmed-article:4058304pubmed:meshHeadingpubmed-meshheading:4058304-...lld:pubmed
pubmed-article:4058304pubmed:meshHeadingpubmed-meshheading:4058304-...lld:pubmed
pubmed-article:4058304pubmed:meshHeadingpubmed-meshheading:4058304-...lld:pubmed
pubmed-article:4058304pubmed:meshHeadingpubmed-meshheading:4058304-...lld:pubmed
pubmed-article:4058304pubmed:meshHeadingpubmed-meshheading:4058304-...lld:pubmed
pubmed-article:4058304pubmed:meshHeadingpubmed-meshheading:4058304-...lld:pubmed
pubmed-article:4058304pubmed:meshHeadingpubmed-meshheading:4058304-...lld:pubmed
pubmed-article:4058304pubmed:meshHeadingpubmed-meshheading:4058304-...lld:pubmed
pubmed-article:4058304pubmed:meshHeadingpubmed-meshheading:4058304-...lld:pubmed
pubmed-article:4058304pubmed:meshHeadingpubmed-meshheading:4058304-...lld:pubmed
pubmed-article:4058304pubmed:meshHeadingpubmed-meshheading:4058304-...lld:pubmed
pubmed-article:4058304pubmed:year1985lld:pubmed
pubmed-article:4058304pubmed:articleTitleSensory, motor, and autonomic neuropathy in patients with multiple symmetric lipomatosis.lld:pubmed
pubmed-article:4058304pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4058304lld:pubmed